|

Cancer Clinical Trials in New York, NY

1881 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLPhase 2<1 mi
E-Mindfulness Approaches for Living After Breast CancerPhase 3<1 mi
Colon Adjuvant Chemotherapy Based on Evaluation of Residual DiseasePhase 2/3<1 mi
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN StudyPhase 2/3<1 mi
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialPhase 2<1 mi
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI TrialPhase 2<1 mi
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaPhase 3<1 mi
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL StudyPhase 3<1 mi
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabPhase 3<1 mi
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerPhase 3<1 mi
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Phase 3<1 mi
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialPhase 2<1 mi
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerPhase 3<1 mi
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerPhase 2/3<1 mi
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerPhase 3<1 mi
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPhase 1/2<1 mi
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaPhase 3<1 mi
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated GlioblastomaPhase 3<1 mi
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)Phase 3<1 mi
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabPhase 3<1 mi
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyPhase 3<1 mi
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group StudyPhase 1/2<1 mi
Project: Every Child for Younger Patients With Cancer—<1 mi
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsPhase 3<1 mi
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaPhase 3<1 mi
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryPhase 3<1 mi
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive MeningiomasPhase 2<1 mi
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)Phase 3<1 mi
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainPhase 3<1 mi
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerPhase 3<1 mi
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerPhase 3<1 mi
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerPhase 3<1 mi
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerPhase 2/3<1 mi
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney CancerPhase 3<1 mi
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPhase 3<1 mi
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung CancerPhase 3<1 mi
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers—<1 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection—<1 mi
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic CancerPhase 1/2<1 mi
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)Phase 2<1 mi
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)Phase 2<1 mi
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryPhase 2<1 mi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerPhase 3<1 mi
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors—<1 mi
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian CancerN/A<1 mi
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerPhase 3<1 mi
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal CancerPhase 4<1 mi
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerPhase 3<1 mi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)Phase 3<1 mi
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR TrialPhase 2/3<1 mi
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerPhase 3<1 mi
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate CancerPhase 3<1 mi
A Study of Questionnaires in Adolescents and Young Adults With Cancer—<1 mi
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)Phase 2<1 mi
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive SurgeryPhase 2<1 mi
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular TumorsN/A<1 mi
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)Phase 1<1 mi
A Study of Herbal Supplements in Cancer Survivors With ConstipationN/A<1 mi
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)Phase 2<1 mi
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma—<1 mi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER StudyPhase 3<1 mi
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of Enfortumab Vedotin in People With Adenoid Cystic CarcinomaPhase 2<1 mi
A Study of Meaning-Centered Psychotherapy for Caregivers to People With CancerN/A<1 mi
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)Phase 3<1 mi
A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic CancerPhase 2<1 mi
Collecting Information About Treatment Results for Patients With Cushing's Syndrome—<1 mi
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationPhase 2<1 mi
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur StudyPhase 3<1 mi
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid LeukemiaPhase 1<1 mi
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial CancerN/A<1 mi
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat CancerPhase 2<1 mi
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With CancerN/A<1 mi
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor CancerPhase 1<1 mi
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary TractPhase 2<1 mi
A Study of Pembrolizumab in People With Ultra-Rare SarcomasPhase 2<1 mi
Post-op T-DM1 in HER-2+ Salivary Gland CarcinomasPhase 2<1 mi
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment—<1 mi
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)Phase 2<1 mi
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerPhase 1/2<1 mi
A Study of Revumenib and Mezigdomide in People With LeukemiaPhase 1/2<1 mi
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease—<1 mi
A Study of a Vaccine in Combination With Beta-glucan in People With NeuroblastomaPhase 2<1 mi
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantPhase 2<1 mi
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryPhase 2<1 mi
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive SurgeryPhase 2<1 mi
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or LegPhase 2<1 mi
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell LymphomaPhase 2<1 mi
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)Phase 2<1 mi
A Study of Elranatamab and Cyclophosphamide in People With Multiple MyelomaPhase 2<1 mi
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialPhase 3<1 mi
A Study of 177Lu-PSMA-617 in People With GliomasPhase 1<1 mi
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous LeukemiaPhase 1<1 mi
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck CancerPhase 2<1 mi
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell LymphomaEarly 1<1 mi
A Study of Botensilimab and Balstilimab for Rectal AdenocarcinomaPhase 2<1 mi
A Study of CRD3874-SI in People With Solid TumorsPhase 1<1 mi
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial CancerPhase 2<1 mi
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentPhase 3<1 mi
A Study Collecting Health Information to Understand and Prevent Gastric Cancer—<1 mi
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma—<1 mi
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas—<1 mi
Glioma Developmental and HyperActive Ras Tumor (DHART) Board—<1 mi
A Study of Ivonescimab in People With LeiomyosarcomaPhase 2<1 mi
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid LeukemiaPhase 2<1 mi
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal CancerPhase 3<1 mi
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)Phase 2<1 mi
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)Phase 1<1 mi
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With CancerN/A<1 mi
A Study of Mirdametinib in Combination With Palbociclib in People With LiposarcomaPhase 1/2<1 mi
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantPhase 2<1 mi
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening—<1 mi
Ulixertinib in People With Histiocytic NeoplasmsPhase 2<1 mi
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDACPhase 2<1 mi
Study of eFT226 in Subjects With Selected Advanced Solid Tumor MalignanciesPhase 1/2<1 mi
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple MyelomaPhase 2<1 mi
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)N/A<1 mi
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell TransplantPhase 2<1 mi
A Study of the Use of 3D Technology to Guide Head and Neck SurgeryN/A<1 mi
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL AmyloidosisPhase 3<1 mi
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialPhase 2<1 mi
A Study of Surgical Techniques During CystectomyPhase 3<1 mi
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal CancerPhase 3<1 mi
A Study of BV-AVD in People With Bulky Hodgkin LymphomaPhase 2<1 mi
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsPhase 2<1 mi
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their PainPhase 1<1 mi
Using a Blood Test and Software Tool to Guide Treatment for Venous ThromboembolismN/A<1 mi
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell CarcinomaPhase 2<1 mi
Groningen International Study on Sentinel Nodes in Vulvar Cancer-IIIPhase 2<1 mi
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell CarcinomaPhase 2<1 mi
Enfortumab Vedotin and Pembrolizumab in People With Bladder CancerPhase 2<1 mi
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic ChangePhase 2<1 mi
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck CancerPhase 1<1 mi
A Study of Response to Standard Treatment Before Surgery in People With Rectal CancerN/A<1 mi
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Phase 2<1 mi
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate CancerPhase 2<1 mi
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid TumorsPhase 2<1 mi
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland CancersPhase 2<1 mi
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromesPhase 1<1 mi
Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal CancerPhase 2<1 mi
A Study of Tarlatamab for People With Prostate CancerPhase 2<1 mi
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)Phase 2<1 mi
Kidney Cancer DNA Registry—<1 mi
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin CancerPhase 1<1 mi
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerPhase 3<1 mi
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsPhase 2<1 mi
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat CancerPhase 3<1 mi
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic LymphomaPhase 2<1 mi
Genomic Profiling in Cancer Patients—<1 mi
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate CancerPhase 1/2<1 mi
A Study of Intra-operative Imaging in Women With Ovarian CancerPhase 3<1 mi
A Study of Ruxolitinib and Duvelisib in People With LymphomaPhase 1<1 mi
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid LeukemiaPhase 2<1 mi
A Study of SER-155 to Treat Diarrhea in People on ImmunotherapyPhase 1<1 mi
A Study of Sotorasib in People With Brain TumorsPhase 1<1 mi
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer—<1 mi
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free HomeN/A<1 mi
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma—<1 mi
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and HypogammaglobulinemiaPhase 2<1 mi
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)Phase 2<1 mi
A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)Phase 2<1 mi
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by SurgeryPhase 2<1 mi
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders—<1 mi
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaPhase 1<1 mi
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy—<1 mi
A Study of Tucatinib and Trastuzumab in People With Rectal CancerPhase 2<1 mi
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaPhase 2<1 mi
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric CancerPhase 2<1 mi
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerPhase 1<1 mi
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)N/A<1 mi
A Study of Teclistamab and Mezigdomide in People With Multiple MyelomaPhase 1<1 mi
A Study of Selinexor in People With Wilms Tumors and Other Solid TumorsPhase 2<1 mi
Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak—<1 mi
Pembrolizumab, Olaparib, and Temozolomide for People With GliomaPhase 2<1 mi
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian CancerPhase 2<1 mi
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG TherapyPhase 3<1 mi
A Study of Multiparametric Ultrasound Imaging MethodsN/A<1 mi
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular LymphomaPhase 2<1 mi
A Study of Pasireotide in People With ProlactinomaPhase 2<1 mi
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and ChemotherapyPhase 2<1 mi
A Dietary Study for People With Multiple MyelomaN/A<1 mi
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)N/A<1 mi
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate CancerPhase 2<1 mi
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer—<1 mi
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate CancerPhase 3<1 mi
A Study of Opportunistic Salpingectomy to Prevent Ovarian CancerN/A<1 mi
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)Phase 1/2<1 mi
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell TransplantPhase 2<1 mi
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)Phase 1<1 mi
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard TreatmentPhase 1<1 mi
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)Phase 1<1 mi
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)Phase 1<1 mi
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II StudyPhase 2<1 mi
Collection of Information to Better Understand Young Onset Colorectal Cancer—<1 mi
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerPhase 3<1 mi
A Study of Isoquercetin in People With Ovarian CancerPhase 2<1 mi
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical CancerPhase 2<1 mi
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms—<1 mi
A Study of Deferoxamine (DFO) in People With Leptomeningeal MetastasisPhase 1<1 mi
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial CancerPhase 3<1 mi
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following TreatmentPhase 2<1 mi
A Study of Ivonescimab in People With Endometrial and Cervical CancersPhase 2<1 mi
A Study of Reduced Dose Radiation Therapy for People With B-Cell LymphomasPhase 3<1 mi
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell CarcinomaPhase 2<1 mi
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular LymphomaPhase 1<1 mi
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell LymphomaPhase 2<1 mi
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE TrialPhase 3<1 mi
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat CancerPhase 2<1 mi
A Study of ADCLEC.syn1 in People With Acute Myeloid LeukemiaPhase 1<1 mi
A Study of Tongue Strength and Endurance Using the Iowa Oral Performance Instrument (IOPI) Tongue Strength Trainer in People With Oral Tongue CanceN/A<1 mi
Acupuncture for People Experiencing Period Loss Due to ChemotherapyPhase 2<1 mi
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic LeukemiaPhase 2<1 mi
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1Phase 2<1 mi
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial CancerEarly 1<1 mi
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple MyelomaPhase 1/2<1 mi
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology—<1 mi
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial CancerN/A<1 mi
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerN/A<1 mi
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal CavityPhase 2/3<1 mi
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)Phase 1<1 mi
A Study of Changes to Prostate ProceduresPhase 3<1 mi
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With OsteosarcomaPhase 2<1 mi
Impact of ICCAN on Cancer Treatment Completion and Quality of Life—<1 mi
A Study of Avutometinib and Defactinib in People With Thyroid CancerPhase 2<1 mi
A Study of Mirdametinib in People With Central Nervous System TumorsPhase 1/2<1 mi
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell TherapyPhase 2<1 mi
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test ResultsN/A<1 mi
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)Phase 2<1 mi
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Phase 3<1 mi
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal CancersPhase 2<1 mi
A Music Therapy Study for Blood Cancer Survivors With Cognitive DifficultiesN/A<1 mi
Study of a Support Program for Quality of Life in Chinese Cancer Patients and SurvivorsN/A<1 mi
Germ Cell Tumor and Testicular Tumor DNA Registry—<1 mi
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity CancerPhase 2/3<1 mi
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With CancerN/A<1 mi
A Study of a Weight Loss Intervention in People With Endometrial CancerEarly 1<1 mi
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With SarcomaN/A<1 mi
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their CaregiversN/A<1 mi
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast CancerPhase 1/2<1 mi
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your JobN/A<1 mi
A Registry for People With T-cell Lymphoma—<1 mi
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer SurvivorsPhase 2<1 mi
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain ControlPhase 3<1 mi
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma—<1 mi
Factors Associated With Breast Cancer Risks and Outcomes—<1 mi
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric CancerPhase 1<1 mi
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast CancerPhase 2<1 mi
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast CancerN/A<1 mi
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized TrialN/A<1 mi
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast CancerPhase 1<1 mi
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast CancerPhase 2<1 mi
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsPhase 2<1 mi
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast CancerPhase 2<1 mi
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term RemissionPhase 2<1 mi
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast CancerPhase 3<1 mi
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer—<1 mi
A Study of Language Interpretation Solutions for People With Breast CancerN/A<1 mi
A Study of a Decision Tool for People Considering Breast Reconstruction SurgeryN/A<1 mi
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast CancerPhase 2<1 mi
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations—<1 mi
A Study of Blood Pressure Control During Cancer TreatmentPhase 2<1 mi
Study of Aerobic Training for People Receiving Chemotherapy for Breast CancerPhase 2<1 mi
Lymphedema Surveillance Study—<1 mi
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast CancerPhase 2<1 mi
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell LymphomaPhase 2<1 mi
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) ProtocolPhase 4<1 mi
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander PlacementPhase 4<1 mi
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast CancerPhase 1<1 mi
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors—<1 mi
A Study of SDX-7320 in Combination With Eribulin for People With Breast CancerPhase 2<1 mi
A Study of Surgery and Radiotherapy in People With Breast CancerPhase 2<1 mi
A Study of Pembrolizumab and Cryoablation in People With Breast CancerPhase 1<1 mi
A Study to Prevent and Improve Sexual Health Concerns for People With Breast CancerN/A<1 mi
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)—<1 mi
A Study of Revaree Plus in People With Breast CancerPhase 4<1 mi
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of DiseasePhase 2<1 mi
A Study of Valemetostat in Combination With Atezolizumab in People With Lung CancerPhase 1<1 mi
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialPhase 3<1 mi
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung CancerPhase 1/2<1 mi
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsPhase 1<1 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1Phase 3<1 mi
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.Phase 1<1 mi
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueN/A<1 mi
Using Urine Samples to Identify Lung Cancer—<1 mi
A Study of ZEN003694 in People With Squamous Cell Lung CancerPhase 2<1 mi
A Study of Sotorasib in People With Non-Small Cell Lung CancerPhase 2<1 mi
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With SurgeryPhase 2<1 mi
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung DiseasePhase 2<1 mi
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the BrainPhase 2<1 mi
A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung CancerPhase 1<1 mi
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerPhase 1/2<1 mi
A Study of Sacituzumab Govitecan in People With MesotheliomaPhase 2<1 mi
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer—<1 mi
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the BrainPhase 2<1 mi
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung CancersPhase 2<1 mi
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung CancerPhase 1/2<1 mi
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung CancerPhase 1/2<1 mi
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaPhase 2<1 mi
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung CancerPhase 2<1 mi
A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and ChestPhase 2<1 mi
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityPhase 2<1 mi
A Study of Hospital-at-Home for People Receiving TarlatamabN/A<1 mi
A Registry for People With Lung Cancer—<1 mi
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)Phase 3<1 mi
A Study of Ivonescimab in People With Non-Small Cell Lung CancerPhase 1/2<1 mi
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung CancerPhase 2<1 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)Phase 2<1 mi
A Study of Lung Cancer Screening in People With Unexplained Weight Loss—<1 mi
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural MesotheliomaN/A<1 mi
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal CancerPhase 2<1 mi
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)Phase 2<1 mi
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialPhase 3<1 mi
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaPhase 2<1 mi
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerPhase 3<1 mi
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyPhase 3<1 mi
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLPhase 2<1 mi
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaPhase 3<1 mi
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Phase 3<1 mi
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate CancerPhase 1<1 mi
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsPhase 2/3<1 mi
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaPhase 3<1 mi
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary TractPhase 3<1 mi
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Phase 3<1 mi
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid TumorsPhase 1/2<1 mi
SLV-154 Treatment of Metastatic Solid TumorsPhase 1<1 mi
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast CancerPhase 1/2<1 mi
A First-in-Human Study of MEN2312 in Adults With Advanced Breast CancerPhase 1<1 mi
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)Phase 3<1 mi
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerPhase 3<1 mi
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation—<1 mi
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)Phase 1/2<1 mi
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsPhase 1<1 mi
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaPhase 3<1 mi
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.N/A<1 mi
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPhase 4<1 mi
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingPhase 3<1 mi
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder CancerPhase 2<1 mi
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-NaïvePhase 1/2<1 mi
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationPhase 3<1 mi
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients—<1 mi
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)Phase 1/2<1 mi
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney CancerPhase 2<1 mi
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTPhase 2<1 mi
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System LymphomaPhase 2<1 mi
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsPhase 2<1 mi
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)—<1 mi
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaPhase 2<1 mi
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerPhase 1<1 mi
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)Phase 2<1 mi
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsPhase 3<1 mi
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Phase 1/2<1 mi
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck CancerPhase 3<1 mi
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AMLPhase 1<1 mi
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsPhase 3<1 mi
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 2<1 mi
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLPhase 2<1 mi
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)Phase 3<1 mi
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)Phase 3<1 mi
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)Phase 2<1 mi
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing LossPhase 3<1 mi
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received TreatmentPhase 1/2<1 mi
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)Phase 1/2<1 mi
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid TumorsPhase 1/2<1 mi
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)Phase 3<1 mi
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase InhibitionPhase 2<1 mi
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal CancerN/A<1 mi
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced CancersPhase 1/2<1 mi
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Phase 1<1 mi
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentPhase 1/2<1 mi
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder CancerPhase 2<1 mi
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)Phase 1/2<1 mi
A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaPhase 2<1 mi
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)Phase 2<1 mi
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract CancerPhase 3<1 mi
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma PatientsPhase 3<1 mi
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLPhase 3<1 mi
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body—<1 mi
A Long-term Study for Participants Previously Treated With Ciltacabtagene AutoleucelPhase 4<1 mi
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT TrialPhase 2<1 mi
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal CancerPhase 2<1 mi
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)Phase 1/2<1 mi
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed OsteosarcomaPhase 2/3<1 mi
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaPhase 2<1 mi
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto—<1 mi
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)Phase 1/2<1 mi
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Phase 3<1 mi
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)Phase 3<1 mi
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaPhase 3<1 mi
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTPhase 2<1 mi
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive ChemotherapyPhase 2<1 mi
Fabry Disease Registry & Pregnancy Sub-registry—<1 mi
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple MyelomaPhase 2<1 mi
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsPhase 1/2<1 mi
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell MalignanciesPhase 1/2<1 mi
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerPhase 3<1 mi
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal CancerPhase 3<1 mi
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 1<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2<1 mi
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3<1 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1<1 mi
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Phase 3<1 mi
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationPhase 3<1 mi
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrencePhase 3<1 mi
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerPhase 3<1 mi
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast CancerPhase 1<1 mi
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsPhase 1<1 mi
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerPhase 3<1 mi
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast CancerPhase 2<1 mi
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPhase 2<1 mi
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerPhase 3<1 mi
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsPhase 1<1 mi
TTX-080 HLA-G Antagonist in Subjects With Advanced CancersPhase 1<1 mi
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionPhase 1<1 mi
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)Phase 3<1 mi
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 2<1 mi
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)Phase 2<1 mi
A Phase 1/1b Study of IAM1363 in HER2 CancersPhase 1<1 mi
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaPhase 3<1 mi
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPhase 1<1 mi
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaPhase 1<1 mi
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsPhase 1/2<1 mi
A Study of Methylprednisolone in People Having Liver SurgeryPhase 3<1 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—<1 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 CirrhosisPhase 2<1 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 3<1 mi
Registry Study for Radiation Therapy Outcomes—<1 mi
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy—<1 mi
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)Phase 1<1 mi
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous MelanomaN/A<1 mi
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects—<1 mi
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.Phase 3<1 mi
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCPhase 3<1 mi
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs—<1 mi
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3<1 mi
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell CarcinomaPhase 3<1 mi
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)Phase 3<1 mi
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate CancerPhase 1/2<1 mi
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate CancerPhase 1<1 mi
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix CancerN/A<1 mi
International Registry for Men With Advanced Prostate Cancer (IRONMAN)—<1 mi
Chatbot to Maximize Hereditary Cancer Genetic Risk AssessmentN/A<1 mi
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaPhase 3<1 mi
Trial of Combined Obstetric Carrier Screening and Hereditary Cancer ScreeningN/A<1 mi
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma SubjectsPhase 1<1 mi
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation—<1 mi
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple MyelomaPhase 3<1 mi
Using Middle School Science Teachers to Address Cancer Health DisparitiesN/A<1 mi
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple MyelomaPhase 3<1 mi
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)Phase 3<1 mi
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)Phase 3<1 mi
The PREDICT Registry:—<1 mi
ATEMPT 2.0: Adjuvant T-DM1 vs THPhase 2<1 mi
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical StudyN/A<1 mi
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsN/A<1 mi
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C MutationPhase 2<1 mi
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung CancerPhase 3<1 mi
A Study of Sigvotatug Vedotin in Advanced Solid TumorsPhase 1<1 mi
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorPhase 3<1 mi
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerPhase 3<1 mi
A Study of BMS986365 in Combination With Degarelix in People With Prostate CancerPhase 2<1 mi
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis FungoidesPhase 1<1 mi
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)Phase 3<1 mi
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)Phase 3<1 mi
Phase IIIb Study of Ribociclib + ET in Early Breast CancerPhase 3<1 mi
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed CancerN/A<1 mi
An Acupuncture Study for Cancer Survivors With Joint PainN/A<1 mi
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated SarcomasPhase 3<1 mi
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes—<1 mi
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments—<1 mi
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical TrialsPhase 4<1 mi
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)Phase 1/2<1 mi
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.Phase 1<1 mi
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)Phase 3<1 mi
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone MarrowPhase 2<1 mi
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerPhase 3<1 mi
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing SarcomaPhase 1/2<1 mi
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon CancerPhase 3<1 mi
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyPhase 3<1 mi
TLN-372 in Advanced KRAS Mutant Solid TumorsPhase 1<1 mi
A Safety Study of SEA-CD70 in Patients With Myeloid MalignanciesPhase 1<1 mi
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction CancerPhase 3<1 mi
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)Phase 3<1 mi
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other TumorsPhase 1/2<1 mi
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)Phase 3<1 mi
Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory NervesN/A<1 mi
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic AdenocarcinomaPhase 2<1 mi
Study of SGR-1505 in Mature B-Cell NeoplasmsPhase 1<1 mi
Study to Evaluate VT3989 in Patients With Metastatic Solid TumorsPhase 1/2<1 mi
Retinoblastoma Phase II Expanded Access Clinical TrialPhase 2<1 mi
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)Phase 1<1 mi
A Study of TAK-505 in Adults With Solid TumorsPhase 1/2<1 mi
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GlioblastomaN/A<1 mi
A Study of YL201 in Patients With Advanced Solid TumorsPhase 1/2<1 mi
Pilot Testing of a Colorectal Cancer Education ProgramN/A<1 mi
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including SarcomasPhase 1<1 mi
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair GenesPhase 1<1 mi
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma PatientsPhase 2<1 mi
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic CarcinomaPhase 1/2<1 mi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerPhase 2<1 mi
Gadopiclenol in Contrast Enhanced MRI of the ProstatePhase 4<1 mi
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaPhase 2<1 mi
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable TreatmentPhase 3<1 mi
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)Phase 3<1 mi
PediRISE FeasibilityN/A<1 mi
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOAPhase 2<1 mi
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialPhase 2/3<1 mi
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)Phase 2/3<1 mi
Testing Gene PilotLX With Latinx Cancer PatientsN/A<1 mi
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell LymphomaPhase 2<1 mi
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLCPhase 1<1 mi
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid TumorsPhase 1/2<1 mi
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related ValuesN/A<1 mi
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBarN/A<1 mi
Tissue Repository: CTCL Collection Protocol—<1 mi
A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid TumorsPhase 1<1 mi
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System—<1 mi
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations—<1 mi
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin LymphomasPhase 1/2<1 mi
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsPhase 1<1 mi
The SUGAR Study; SBRT and Relugolix) for Prostate CancerPhase 2<1 mi
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)Phase 2<1 mi
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or ParagangliomaPhase 2<1 mi
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing SurveillanceN/A<1 mi
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBCPhase 2<1 mi
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1Phase 2<1 mi
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With NeuroblastomaPhase 2<1 mi
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate CancerPhase 1<1 mi
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment—<1 mi
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 SystemPhase 1/2<1 mi
Excision of Lymph Node Trial (EXCILYNT) (Mel69)N/A<1 mi
Identification and Treatment Of Micrometastatic Disease in Stage III Colon CancerPhase 3<1 mi
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)Phase 2<1 mi
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal MelanomaPhase 2/3<1 mi
Neurofibromatosis (NF) Registry Portal—<1 mi
Avutometinib and Defactinib in Diffuse Gastric CancerPhase 2<1 mi
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell CarcinomaPhase 1<1 mi
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1<1 mi
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube CancerPhase 3<1 mi
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)Phase 3<1 mi
Actinium Therapy for Late-stage Aggressive SarcomasPhase 1<1 mi
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer—<1 mi
Chronic CED of TPT for Recurrent Malignant GliomaPhase 1<1 mi
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)Phase 2<1 mi
Study of a Communication Training Intervention for Large B-Cell Lymphoma ProvidersN/A<1 mi
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid TumorsPhase 1<1 mi
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)Phase 2<1 mi
Mobile Health Application (PACT) to Improve Engagement in Advance Care PlanningN/A<1 mi
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced CancerN/A<1 mi
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive MalignanciesPhase 4<1 mi
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.Phase 3<1 mi
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCCPhase 2<1 mi
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected TumorsPhase 1<1 mi
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral NeuropathyPhase 3<1 mi
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple MyelomaPhase 1/2<1 mi
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AMLPhase 1/2<1 mi
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell LymphomaPhase 1<1 mi
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)Phase 3<1 mi
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaPhase 3<1 mi
Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural EffusionsN/A<1 mi
R-MVST Cells for Treatment of Viral InfectionsPhase 1<1 mi
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors—<1 mi
A New Psychotherapy Intervention for Older Cancer PatientsN/A<1 mi
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)Phase 3<1 mi
Intent of Surgery for IPMN—<1 mi
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBMPhase 1/2<1 mi
An Acupuncture Study for People At High Risk for SepsisPhase 2<1 mi
A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral EventsPhase 2<1 mi
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerPhase 2/3<1 mi
Decision Aid (DA) for Renal PatientsN/A<1 mi
Environmental Factors and Thyroid Cancer—<1 mi
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia IIPhase 1/2<1 mi
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With EzabenlimabPhase 1<1 mi
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaEarly 1<1 mi
Cord Blood Transplant in Adults With Blood CancersPhase 2<1 mi
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)Phase 2/3<1 mi
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)Phase 3<1 mi
Study of CAR-T Therapy in Older Patients—<1 mi
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue SarcomaPhase 2<1 mi
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin LymphomaPhase 2<1 mi
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerPhase 1<1 mi
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBMPhase 3<1 mi
Asciminib Roll-over StudyPhase 4<1 mi
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid TumorsPhase 2<1 mi
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)Phase 3<1 mi
FITting Non-invasive Tests in Lynch Syndrome Surveillance—<1 mi
Ablative Therapy in the Management of Prostate Cancer—<1 mi
Epco, Zanu, Ritux for R/R FL or MZLPhase 2<1 mi
A Study of Emapalumab for Pediatric Aplastic AnemiaPhase 2<1 mi
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)Phase 1/2<1 mi
Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT StudyPhase 2<1 mi
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia VeraPhase 3<1 mi
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic LeukemiaPhase 1/2<1 mi
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Phase 2<1 mi
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid TumorsPhase 1<1 mi
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).—<1 mi
A Study of PHST001 in Advanced Solid TumorsPhase 1<1 mi
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate CancerPhase 1<1 mi
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid TumorsPhase 1<1 mi
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)Phase 1/2<1 mi
Study of How People Make Decisions About Prostate Cancer Risk—<1 mi
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate CancerPhase 1<1 mi
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate CancerPhase 2<1 mi
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)Phase 1/2<1 mi
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode SystemN/A<1 mi
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaPhase 3<1 mi
Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer ScreeningN/A<1 mi
IVIG for Infection Prevention After CAR-T-Cell TherapyPhase 2<1 mi
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)Phase 2<1 mi
Adoptive Cell Therapy Long-term Follow-up (LTFU) StudyPhase 1<1 mi
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)Phase 1<1 mi
Cryopreservation of Ovarian TissueN/A<1 mi
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid TumorsPhase 1/2<1 mi
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)Phase 1<1 mi
DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaPhase 1<1 mi
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue SarcomaPhase 1/2<1 mi
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV MelanomaPhase 2<1 mi
A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
First-in-Human Study of ADCE-D01 in Soft Tissue SarcomaPhase 1/2<1 mi
First in Human Study of TORL-1-23 in Participants With Advanced CancerPhase 1<1 mi
A Multi Center Study of Sexual Toxicities After Radiotherapy—<1 mi
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerPhase 2<1 mi
Blue Light Cystoscopy With Cysview® Registry—<1 mi
Precision Medicine Study—<1 mi
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin LymphomaPhase 4<1 mi
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With CancerPhase 3<1 mi
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment RegimenPhase 3<1 mi
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 MutationPhase 1/2<1 mi
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
Epcoritamab and Rituximab for First-line Follicular LymphomaPhase 2<1 mi
Changes Associated With H. Pylori and Gastric Carcinogenesis—<1 mi
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsPhase 3<1 mi
MB-105 in Patients With CD5 Positive T-cell LymphomaPhase 2<1 mi
Food and Microbiome Longitudinal Investigation (FAMiLI)—<1 mi
SPEARHEAD-3 Pediatric StudyPhase 1/2<1 mi
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialPhase 2<1 mi
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)Phase 1<1 mi
A Study of ZL-1310 in Participants With Selected Solid TumorsPhase 1/2<1 mi
Cord Blood Transplantation in Children and Young Adults With Blood CancerPhase 2<1 mi
(Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisPhase 2<1 mi
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)Phase 3<1 mi
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate CancerPhase 1<1 mi
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)Phase 1/2<1 mi
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX OverexpressionPhase 1/2<1 mi
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate CancerPhase 2<1 mi
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid TumorsPhase 1<1 mi
A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)Phase 1/2<1 mi
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsPhase 1<1 mi
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI DiscontinuationPhase 2<1 mi
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)Phase 2/3<1 mi
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic AdenocarcinomaPhase 2<1 mi
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients—<1 mi
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)Phase 1/2<1 mi
A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid LeukemiasPhase 1<1 mi
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related DiseasesPhase 1<1 mi
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials—<1 mi
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated LiposarcomaPhase 1<1 mi
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic LeukemiaPhase 3<1 mi
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid TumorsPhase 1<1 mi
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3Phase 1<1 mi
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid TumorsPhase 1<1 mi
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsPhase 1/2<1 mi
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell LymphomaPhase 2<1 mi
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyPhase 2<1 mi
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPhase 2/3<1 mi
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid TumorsPhase 1<1 mi
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaPhase 1<1 mi
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid TumorsPhase 1<1 mi
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)Phase 2<1 mi
Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)Phase 1<1 mi
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)Phase 2<1 mi
Tissue Collection for Drug Screening and Bioanalysis—<1 mi
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid TumorsPhase 1<1 mi
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionPhase 2<1 mi
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple MyelomaN/A<1 mi
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPhase 4<1 mi
Combination Therapy for the Treatment of Diffuse Midline GliomasPhase 2<1 mi
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate CancerPhase 2<1 mi
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate CancerPhase 1<1 mi
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic SyndromesPhase 1<1 mi
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALPhase 1<1 mi
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)Phase 2<1 mi
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPhase 2<1 mi
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaPhase 1<1 mi
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate CancerPhase 2<1 mi
Childhood Cancer Survivor Study—<1 mi
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular LymphomaPhase 3<1 mi
Adaptive Radiation in Anal CancerN/A<1 mi
International Rare Histiocytic Disorders Registry (IRHDR)—<1 mi
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisPhase 1<1 mi
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative NeoplasmPhase 1<1 mi
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid LeukemiaPhase 1/2<1 mi
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesPhase 1<1 mi
Pancreas Registry and High Risk Registry—<1 mi
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell CarcinomaPhase 3<1 mi
Carboplatin or Olaparib for BRcA Deficient Prostate CancerPhase 2<1 mi
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Phase 3<1 mi
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)Phase 1/2<1 mi
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric GliomasPhase 1/2<1 mi
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab AdizutecanPhase 2<1 mi
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATEPhase 4<1 mi
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaPhase 1/2<1 mi
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal TherapyPhase 1/2<1 mi
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)—<1 mi
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell SarcomaPhase 2<1 mi
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AMLPhase 1<1 mi
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.Phase 2<1 mi
Anti-GD2 ADC M3554 in Advanced Solid TumorsPhase 1<1 mi
Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder CancerPhase 2<1 mi
A Study of ASP3082 in Adults With Advanced Solid TumorsPhase 1<1 mi
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial CancerPhase 2<1 mi
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.Phase 1/2<1 mi
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and RevumenibPhase 1/2<1 mi
Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer PatientsN/A<1 mi
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)Phase 1/2<1 mi
DALY II USA/ MB-CART2019.1 for DLBCLPhase 2<1 mi
Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell CarcinomaEarly 1<1 mi
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)Phase 1<1 mi
Neoadjuvant Darovasertib in Primary Uveal MelanomaPhase 3<1 mi
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell LymphomaPhase 1<1 mi
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerPhase 1/2<1 mi
Chinese American Cancer Survivors Writing StudyN/A<1 mi
A Phase 3 Study of Ersodetug in Patients With Tumor HyperinsulinismPhase 3<1 mi
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMPhase 1<1 mi
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)Phase 1<1 mi
FUS Etoposide for DMGPhase 1<1 mi
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)Phase 3<1 mi
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's TransformationPhase 2<1 mi
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsPhase 1<1 mi
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorsPhase 1<1 mi
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252Phase 1<1 mi
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete RemissionPhase 2<1 mi
R-MVST Cells for Treatment of Viral Infections in Children and Young AdultsPhase 1<1 mi
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerPhase 3<1 mi
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyPhase 3<1 mi
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisPhase 2/3<1 mi
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.Phase 2<1 mi
Study of SGR-3515 In Participants With Advanced Solid Tumors.Phase 1<1 mi
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) PirtobrutinibPhase 4<1 mi
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)Phase 1/2<1 mi
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed GlioblastomaPhase 2<1 mi
Study of NXC-201 CAR-T in Patients With Light Chain (AL) AmyloidosisPhase 1/2<1 mi
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)Phase 1<1 mi
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)Phase 1/2<1 mi
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCsN/A<1 mi
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid TumorsPhase 1/2<1 mi
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound—<1 mi
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder CancerPhase 1<1 mi
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer SurvivorsN/A<1 mi
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular LymphomaPhase 3<1 mi
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After TreatmentPhase 1<1 mi
QTX3034 in Patients With KRAS G12D MutationPhase 1<1 mi
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate CancerPhase 2<1 mi
Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)N/A<1 mi
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal FunctionPhase 2<1 mi
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryN/A<1 mi
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.Phase 1/2<1 mi
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian CancerPhase 3<1 mi
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic LeukemiaPhase 2<1 mi
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPhase 1/2<1 mi
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.Phase 3<1 mi
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal MelanomaPhase 3<1 mi
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem TransplantationPhase 1<1 mi
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromePhase 1<1 mi
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients With CLL or SLLPhase 2<1 mi
Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid TumorsPhase 1/2<1 mi
Characterization of Hyperpolarized Pyruvate MRI ReproducibilityN/A<1 mi
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)Phase 1<1 mi
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to TreatmentPhase 2<1 mi
A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell LymphomasPhase 1/2<1 mi
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior ImmunotherapyPhase 1<1 mi
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban PopulationsN/A<1 mi
Precision-Based Genomics in Prostate Cancer—<1 mi
Trastuzumab Deruxtecan (T-DXd) for People With Brain CancerPhase 2<1 mi
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)Phase 1<1 mi
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic CancerPhase 2<1 mi
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)Phase 1/2<1 mi
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer—<1 mi
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromePhase 1<1 mi
A Study of Avutometinib for People With Solid Tumor CancersPhase 1<1 mi
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid MalignanciesPhase 1<1 mi
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerPhase 1<1 mi
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Phase 1<1 mi
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIPhase 2<1 mi
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)Phase 3<1 mi
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCTPhase 1/2<1 mi
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer SurvivorsPhase 3<1 mi
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)Phase 3<1 mi
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaPhase 2<1 mi
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable CancersPhase 1<1 mi
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric CancerPhase 3<1 mi
A Study of CS5001 in Patients With Advanced Solid Tumors and LymphomasPhase 1<1 mi
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell CarcinomaPhase 3<1 mi
AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)Phase 1/2<1 mi
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid TumorsN/A<1 mi
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 MutationPhase 1<1 mi
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaPhase 1<1 mi
Observing People With Desmoid-Type Fibromatosis—<1 mi
A Study of MGC028 in Participants With Advanced Solid TumorsPhase 1<1 mi
Screening for AL Amyloidosis in Smoldering Multiple Myeloma—<1 mi
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal AdenocarcinomaPhase 3<1 mi
Study of REM-422 in Patients With AML or Higher Risk MDSPhase 1<1 mi
Simple Bone Cysts in KidsPhase 3<1 mi
Colonoscopy vs Stool Testing for Older Adults With Colon PolypsN/A<1 mi
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)—<1 mi
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)Phase 3<1 mi
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic SyndromePhase 1<1 mi
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancErN/A<1 mi
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy—<1 mi
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian CancerPhase 1<1 mi
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)—<1 mi
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active SurveillancePhase 2<1 mi
A Study of CTD402 in T-ALL/LBL PatientsPhase 1/2<1 mi
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)Phase 1/2<1 mi
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid TumoursPhase 1/2<1 mi
Stereotactic MRI-guided Focused Ultrasound MesencephalotomyN/A<1 mi
Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal CarcinomaPhase 2<1 mi
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline TherapyPhase 2<1 mi
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated GliomaPhase 1/2<1 mi
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade DysplasiaN/A<1 mi
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate CancerPhase 3<1 mi
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and LymphomaPhase 1/2<1 mi
Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous MetastasesPhase 1<1 mi
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersPhase 2<1 mi
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial CarcinomaPhase 2/3<1 mi
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial CancerPhase 1/2<1 mi
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesPhase 1<1 mi
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell CancerPhase 2<1 mi
RFA for Superficial LipomasN/A<1 mi
Pan Tumor Rollover StudyPhase 2<1 mi
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)Phase 2<1 mi
Imetelstat Combinations in Relapsed AMLPhase 1<1 mi
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor—<1 mi
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsPhase 1/2<1 mi
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerPhase 2/3<1 mi
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE TrialPhase 3<1 mi
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer—<1 mi
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerPhase 3<1 mi
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors—<1 mi
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerPhase 2<1 mi
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9Phase 1/2<1 mi
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol—<1 mi
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)Phase 1<1 mi
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadPhase 2<1 mi
A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer TreatmentN/A<1 mi
TLN-121 in Relapsed or Refractory Non-Hodgkin LymphomasPhase 1<1 mi
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine GliomaPhase 1<1 mi
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) TrialPhase 2<1 mi
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous MelanomaPhase 3<1 mi
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade GliomaPhase 1<1 mi
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell MalignanciesPhase 1/2<1 mi
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.Phase 1/2<1 mi
A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsPhase 1<1 mi
Tislelizumab in People With Colorectal CancerPhase 2<1 mi
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)Phase 3<1 mi
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsPhase 2/3<1 mi
Prospective Study to Assess a Diagnostic Aid for Cancer—<1 mi
NYC Cancer Outreach Network in Neighborhoods for Equity and Community TranslationN/A<1 mi
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1<1 mi
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or UbamatamabPhase 1/2<1 mi
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)Phase 2<1 mi
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions—<1 mi
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)Phase 1<1 mi
Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid TumoursPhase 1/2<1 mi
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Phase 1<1 mi
ACTengine® IMA203 Combined With mRNA-4203Phase 1<1 mi
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian CancerPhase 2<1 mi
First-in-Human Trial of DS-2243a in Participants With Advanced Solid TumorsPhase 1<1 mi
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic SyndromesPhase 1<1 mi
Tumor Microenvironment Analysis of Prostate Cancer Metastasis—<1 mi
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic LeukemiaPhase 1<1 mi
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer PainN/A<1 mi
Leading in MPNs Beyond Ruxolitinib in Combo With T-RegsPhase 1<1 mi
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk FactorsN/A<1 mi
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)Phase 1/2<1 mi
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce RecurrencePhase 2<1 mi
Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRCPhase 1/2<1 mi
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas—<1 mi
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)N/A<1 mi
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)Phase 2<1 mi
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaPhase 1/2<1 mi
Comprehensive Assessment of Cancer Theranostic ResponseN/A<1 mi
Mechanisms of Resistance to PSMA Radioligand Therapy—<1 mi
A Study to Evaluate Efficacy and Safety of Ciltacabtagene AutoleucelPhase 2<1 mi
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active SurveillancePhase 2<1 mi
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)Phase 3<1 mi
A Phase 1 Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid TumorsPhase 1<1 mi
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)Phase 1/2<1 mi
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantPhase 2/3<1 mi
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerPhase 2<1 mi
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions—<1 mi
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)Phase 3<1 mi
Evaluation of Grief Therapy Approaches for Bereaved ParentsN/A<1 mi
Personalized Models for Cancer Research—<1 mi
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMPhase 3<1 mi
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After ImmunotherapyPhase 2/3<1 mi
Registry for Esophageal and Gastroesophageal Junction Cancer—<1 mi
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic AlterationsPhase 2<1 mi
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early RelapsePhase 2<1 mi
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)Phase 1/2<1 mi
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic CancersN/A<1 mi
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NETPhase 3<1 mi
Photopheresis in Early-stage Mycosis FungoidesPhase 2<1 mi
A Study of Azenosertib (ZN-c3) in Patients With Ovarian CancerPhase 1<1 mi
Study of AZD0754 in Participants With Metastatic Prostate CancerPhase 1/2<1 mi
New MRI Biomarkers in Head and Neck Cancers—<1 mi
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaPhase 2<1 mi
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerPhase 1<1 mi
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerPhase 3<1 mi
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma—<1 mi
Surgical Pembro +/- Olaparib w TMZ for rGBMPhase 2<1 mi
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)Phase 1/2<1 mi
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaPhase 3<1 mi
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)Phase 1/2<1 mi
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial CarcinomaPhase 1<1 mi
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyPhase 3<1 mi
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaPhase 1<1 mi
Cabozantinib for Patients With Recurrent or Progressive MeningiomaPhase 2<1 mi
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With CancerPhase 1<1 mi
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder CancerPhase 3<1 mi
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-TransplantPhase 1/2<1 mi
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate CancerPhase 1<1 mi
Two Fraction Prostate SBRT With DIL SIBPhase 1<1 mi
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal CancerPhase 1<1 mi
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic PhasePhase 2<1 mi
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS TumorsPhase 1/2<1 mi
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomidePhase 3<1 mi
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)Phase 1/2<1 mi
A Study of LY4584180 in Adult Participants With Previously Treated Blood CancersPhase 1<1 mi
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and ParagangliomaPhase 2<1 mi
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer—<1 mi
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell LymphomaPhase 3<1 mi
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin LymphomaPhase 1<1 mi
Radiofrequency Ablation Study in LatinX PatientsN/A<1 mi
Amping up With PemJAKPhase 2<1 mi
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic CancerPhase 2/3<1 mi
Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar CarcinomaPhase 1/2<1 mi
Pancreatic Cancer Early Detection Consortium—<1 mi
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted ChemotherapyPhase 2<1 mi
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)Phase 1<1 mi
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction—<1 mi
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerPhase 1/2<1 mi
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and EpendymomaN/A<1 mi
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)Phase 3<1 mi
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract CancerPhase 3<1 mi
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)Phase 3<1 mi
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided RadiotherapyN/A<1 mi
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsPhase 1<1 mi
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerPhase 3<1 mi
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid TumorsPhase 1<1 mi
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCPhase 3<1 mi
Trial of Ixazomib for Kaposi SarcomaPhase 2<1 mi
Teclistamab-Daratumumab in AL AmyloidosisPhase 2<1 mi
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
Screening Women With Prior HPV for Anal NeoplasiaN/A<1 mi
A Study of DaratumumabPhase 3<1 mi
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasPhase 1/2<1 mi
A Study of Time-Restricted Eating in Childhood Cancer SurvivorsN/A<1 mi
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis—<1 mi
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)Phase 1<1 mi
Concurrent XRD-0394 With Radiation Therapy for High Grade GliomasEarly 1<1 mi
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic ChemotherapyPhase 2<1 mi
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)Phase 2<1 mi
An Extension Study for Patients Previously Enrolled in Studies With PelabresibPhase 3<1 mi
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1Phase 2/3<1 mi
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and RelatlimabPhase 4<1 mi
A First-in-Human Study of YL217 in Patients With Advanced Solid TumorsPhase 1<1 mi
Limited-duration TeclistamabPhase 2<1 mi
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesPhase 1<1 mi
Pembrolizumab, Ibrutinib and Rituximab in PCNSLPhase 1/2<1 mi
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront ChemoimmunotherapyPhase 2<1 mi
Universal Genetic Testing for Cancer Risk ReductionN/A<1 mi
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaPhase 2<1 mi
Brentuximab Vedotin in Early Stage Hodgkin LymphomaPhase 3<1 mi
Sacral Neuromodulation for Male Overactive Bladder (MOAB)N/A<1 mi
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease—<1 mi
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma—<1 mi
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) StudyPhase 3<1 mi
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.Phase 4<1 mi
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study—<1 mi
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaPhase 2<1 mi
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AAPhase 1/2<1 mi
Neuroblastoma Maintenance Therapy TrialPhase 2<1 mi
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) AmyloidosisPhase 1/2<1 mi
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment—<1 mi
RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study—<1 mi
MMRC Horizon One: RRMM (MMRC-099)Phase 2<1 mi
A Study of ASP1002 in Adults for Treatment of Solid TumorsPhase 1<1 mi
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsPhase 2<1 mi
A Study of 177Lu-FAP-2286 in Advanced Solid TumorsPhase 1/2<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)Phase 1/2<1 mi
Lurbinectedin in FET-Fused TumorsPhase 1/2<1 mi
Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsPhase 2<1 mi
Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell LymphomaPhase 2<1 mi
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)Phase 3<1 mi
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Phase 1/2<1 mi
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell MalignanciesPhase 1/2<1 mi
A First-in-Human Trial of DS3790a in Participants With Hematological MalignanciesPhase 1/2<1 mi
Neurocutaneous Melanocytosis Registry—<1 mi
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell LymphomaPhase 1<1 mi
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX GenesPhase 2<1 mi
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerPhase 3<1 mi
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)Phase 2<1 mi
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid TumorsPhase 1/2<1 mi
Fitness and Nutrition in GliomaN/A<1 mi
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid TumorsPhase 1<1 mi
CD4CAR for CD4+ Leukemia and LymphomaPhase 1<1 mi
A Study to Evaluate INCA035784 in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
Primary Tumor Research and Outcomes Network—<1 mi
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationPhase 2<1 mi
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or AstrocytomaPhase 1<1 mi
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 3<1 mi
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care TreatmentsPhase 1<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; CarfilzomibPhase 1/2<1 mi
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesPhase 2<1 mi
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort StudyN/A<1 mi
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerPhase 3<1 mi
Clinical Trial of Approaches to Prostate Cancer SurgeryN/A<1 mi
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisPhase 3<1 mi
Safety and Tolerability Study of GIM-531 in Advanced Solid TumorsPhase 1/2<1 mi
Psychotherapy Intervention for Latinos With Adv CancerN/A<1 mi
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.Phase 3<1 mi
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)Phase 1/2<1 mi
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)Phase 1<1 mi
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of PreventionN/A<1 mi
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial CancerPhase 1/2<1 mi
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone AcetatePhase 2<1 mi
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck CancerPhase 3<1 mi
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate TreatmentPhase 3<1 mi
Upright MRI for Prostate Cancer Screening—<1 mi
A Study of EP0031 in Patients With Advanced RET-altered MalignanciesPhase 1/2<1 mi
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsPhase 2<1 mi
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid TumorsPhase 1<1 mi
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsPhase 1/2<1 mi
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaPhase 3<1 mi
Pacritinib in CMMLPhase 1/2<1 mi
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic CancerPhase 1/2<1 mi
Study of ORIC-944 in Patients With Metastatic Prostate CancerPhase 1<1 mi
A Study of PYX-201 in Advanced Solid TumorsPhase 1<1 mi
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsPhase 2<1 mi
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal CancerPhase 1/2<1 mi
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to TherapyPhase 1<1 mi
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study—<1 mi
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaPhase 2<1 mi
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaPhase 1/2<1 mi
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate CancerPhase 2<1 mi
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)N/A<1 mi
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)Phase 1/2<1 mi
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced MalignanciesPhase 1/2<1 mi
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALLPhase 2<1 mi
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)—<1 mi
A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid TumorsPhase 1<1 mi
The Ambient Light Multiple Myeloma StudyN/A<1 mi
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)Phase 3<1 mi
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaPhase 1/2<1 mi
European Prospective Investigation Into Childhood Cancer—<1 mi
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell TumoursPhase 3<1 mi
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple MyelomaPhase 1<1 mi
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaPhase 2<1 mi
Metastatic Leiomyosarcoma Biomarker Protocol—<1 mi
rTMS for Postoperative Brain Tumor PatientsN/A<1 mi
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort—<1 mi
Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and ProvidersN/A<1 mi
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) CancersPhase 1/2<1 mi
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity TrialPhase 2<1 mi
A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid LeukemiasPhase 1<1 mi
Collection and Storage of Tissue and Blood Samples From Patients With Cancer—<1 mi
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory LymphomaPhase 1<1 mi
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)Phase 2<1 mi
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsPhase 1<1 mi
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal CancerPhase 4<1 mi
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)Phase 2<1 mi
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple MyelomaPhase 1/2<1 mi
Study of INCA036978 in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
Efficacy and Safety of the CG-100 Intraluminal Bypass DeviceN/A<1 mi
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T TherapyPhase 2<1 mi
Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerN/A<1 mi
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaPhase 1/2<1 mi
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell LymphomasPhase 1<1 mi
Retrospective Review of Esophageal Cancer at MSKCC—<1 mi
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors—<1 mi
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies—<1 mi
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCLN/A<1 mi
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPERPhase 2<1 mi
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid TumorsPhase 1/2<1 mi
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid CarcinomaPhase 1<1 mi
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AMLPhase 3<1 mi
Psilocybin Therapy in Advanced CancerPhase 2/3<1 mi
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic LeukemiaPhase 2<1 mi
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)Phase 2<1 mi
Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionPhase 1/2<1 mi
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)Phase 3<1 mi
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian CancerPhase 1/2<1 mi
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the BladderPhase 1/2<1 mi
Avapritinib With Decitabine in Patients With SM-AHNPhase 1<1 mi
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary DiversionN/A<1 mi
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin OintmentPhase 1/2<1 mi
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid TumorsPhase 1<1 mi
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCCPhase 2/3<1 mi
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PETEarly 1<1 mi
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell TransplantationPhase 3<1 mi
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome—<1 mi
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal CancerPhase 3<1 mi
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsPhase 1<1 mi
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia—<1 mi
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed GlioblastomaPhase 1/2<1 mi
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness—<1 mi
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)Phase 1<1 mi
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical TrialsPhase 3<1 mi
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant TumorsPhase 1/2<1 mi
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 SystemPhase 1/2<1 mi
Sequential Therapy in Multiple Myeloma Guided by MRD AssessmentsPhase 2<1 mi
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous PolypsN/A<1 mi
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 1<1 mi
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerPhase 2<1 mi
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.Phase 1/2<1 mi
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)—<1 mi
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial CancerPhase 1<1 mi
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher RiskN/A<1 mi
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCLPhase 3<1 mi
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers—<1 mi
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid LeukemiaPhase 1<1 mi
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid TumorsPhase 2<1 mi
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)Phase 1<1 mi
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaPhase 1<1 mi
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D MutationPhase 1<1 mi
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaPhase 1<1 mi
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia GravisPhase 3<1 mi
Psychotherapy Intervention for Latinos With Advanced CancerN/A<1 mi
Investigations of Reproductive Cancers in Women—<1 mi
Study of IBI3020 Treatment in Participants With Late-Stage Solid TumorsPhase 1<1 mi
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)Phase 1<1 mi
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersPhase 1/2<1 mi
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic LeukemiaPhase 1/2<1 mi
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesPhase 1<1 mi
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCPhase 3<1 mi
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor CancerPhase 1/2<1 mi
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple MyelomaPhase 3<1 mi
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) InhibitorsPhase 3<1 mi
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaPhase 1/2<1 mi
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)Phase 1<1 mi
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically RemovedPhase 1/2<1 mi
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy SpecimenN/A<1 mi
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerPhase 1/2<1 mi
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid TumorsPhase 1<1 mi
Longitudinal Oral Microbiome Sampling for BE—<1 mi
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid HemangioendotheliomaPhase 2<1 mi
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing ChemotherapyPhase 2<1 mi
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)N/A<1 mi
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children—<1 mi
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer SurvivorsPhase 4<1 mi
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersPhase 1<1 mi
TSC Biosample Repository and Natural History Database—<1 mi
NYSCF Scientific Discovery Biobank—<1 mi
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Phase 1<1 mi
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)Phase 3<1 mi
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has SpreadPhase 1/2<1 mi
A Study of LY4257496 in Participants With Cancer (OMNIRAY)Phase 1<1 mi
Combined Immunotherapies in Metastatic ER+ Breast CancerPhase 2<1 mi
Converting HR+ Breast Cancer Into an Individualized VaccinePhase 2<1 mi
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients—<1 mi
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast CancerPhase 4<1 mi
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Phase 3<1 mi
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad OncN/A<1 mi
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast CancerEarly 1<1 mi
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast CancerN/A<1 mi
Study of AVZO-021 in Patients With Advanced Solid TumorsPhase 1/2<1 mi
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyPhase 3<1 mi
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)Phase 1/2<1 mi
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationPhase 1/2<1 mi
Two Versus One Week Breast Radiotherapy (RT)Phase 3<1 mi
A Study of LY4337713 in Participants With FAP-Positive Solid TumorsPhase 1<1 mi
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerPhase 2<1 mi
A Study of Tetrathiomolybdate (TM) Plus CapecitabinePhase 1/2<1 mi
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsPhase 1/2<1 mi
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesPhase 1/2<1 mi
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast CancerPhase 3<1 mi
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast CancerPhase 1<1 mi
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before SurgeryN/A<1 mi
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid TumorsPhase 1<1 mi
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer—<1 mi
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania—<1 mi
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesPhase 1/2<1 mi
A Study of XMT-1660 in Participants With Solid TumorsPhase 1<1 mi
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast CancerPhase 1<1 mi
The Cancer of the Pancreas Screening-5 CAPS5)StudyPhase 3<1 mi
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)Phase 1/2<1 mi
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Phase 3<1 mi
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaPhase 1<1 mi
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsPhase 3<1 mi
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursPhase 1<1 mi
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)N/A<1 mi
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)Phase 2<1 mi
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)—<1 mi
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer PatientsPhase 1/2<1 mi
Study of INCB123667 in Subjects With Advanced Solid TumorsPhase 1<1 mi
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid TumorsPhase 1/2<1 mi
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid TumorsPhase 1/2<1 mi
Breast Elasticity Imaging During Neoadjuvant ChemotherapyN/A<1 mi
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPhase 2<1 mi
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)Phase 2/3<1 mi
Pancreatic Cancer Genetics—<1 mi
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerPhase 3<1 mi
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Phase 3<1 mi
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerN/A<1 mi
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense BreastsN/A<1 mi
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsN/A<1 mi
Elacestrant in Advanced Triple Positive Breast CancerPhase 1/2<1 mi
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast CancerN/A<1 mi
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationPhase 1<1 mi
First in Human Study of TUB-030 in Patients With Advanced Solid TumorsPhase 1/2<1 mi
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During SurgeryPhase 1/2<1 mi
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain MetastasesPhase 1/2<1 mi
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles—<1 mi
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast CancerPhase 1/2<1 mi
IMPACT Trial: Intervention to iMProve AdherenCe EquitablyN/A<1 mi
An Ophthalmic Safety Study in Patients With Breast Cancer—<1 mi
Optimizing Surgical Decisions in Young Adults With Breast CancerN/A<1 mi
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerPhase 1/2<1 mi
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCsPhase 1<1 mi
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients—<1 mi
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentPhase 2<1 mi
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast CancerPhase 1<1 mi
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast CancerPhase 1<1 mi
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You—<1 mi
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton TherapyPhase 3<1 mi
Breast Cancer Implementation Science Study With Educational InterventionN/A<1 mi
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)N/A<1 mi
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida—<1 mi
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsPhase 1<1 mi
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical TrialPhase 2<1 mi
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)N/A<1 mi
Opioid Dispensing Device for Post-Operative Pain in Cancer PatientsN/A<1 mi
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast CancerPhase 1<1 mi
Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening—<1 mi
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerPhase 3<1 mi
Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital.N/A<1 mi
A Study of Mental Health Care in People With CancerN/A<1 mi
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesPhase 1<1 mi
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPhase 1/2<1 mi
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers—<1 mi
Multilevel Intervention for Precision OncologyN/A<1 mi
Empathic Communication Skills (ECS) TrainingN/A<1 mi
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid MalignanciesPhase 1/2<1 mi
A Study of LY4175408 in Participants With Advanced CancerPhase 1<1 mi
A Phase I/II Study of VLS-1488 in Subjects With Advanced CancerPhase 1/2<1 mi
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsPhase 1<1 mi
DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung CancerPhase 2<1 mi
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)Phase 3<1 mi
A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid TumorsPhase 1/2<1 mi
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%Phase 3<1 mi
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2Phase 1<1 mi
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D MutationPhase 1<1 mi
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor MalignanciesPhase 1/2<1 mi
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2Phase 1<1 mi
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer—<1 mi
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsPhase 1<1 mi
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionPhase 1/2<1 mi
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLCPhase 2<1 mi
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsPhase 3<1 mi
GEMINI-NSCLC: NSCLC Biomarker Study—<1 mi
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced MalignanciesPhase 1<1 mi
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossPhase 1/2<1 mi
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLCPhase 2<1 mi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsPhase 1/2<1 mi
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)Phase 3<1 mi
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionPhase 1/2<1 mi
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD MutationsPhase 3<1 mi
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1<1 mi
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLCPhase 3<1 mi
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)Phase 2<1 mi
Phase II Trial of Lung ChemoemobolizationPhase 2<1 mi
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)—<1 mi
Safety and Efficacy of OBX-115 in Advanced Solid TumorsPhase 1/2<1 mi
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC PatientsPhase 1/2<1 mi
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell CarcinomasPhase 1<1 mi
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase 3<1 mi
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLCPhase 1/2<1 mi
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsPhase 1<1 mi
A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)Phase 1<1 mi
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLCPhase 2<1 mi
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)Phase 3<1 mi
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsPhase 1<1 mi
Pediatric Long-Term Follow-up and Rollover StudyPhase 4<1 mi
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung CancerPhase 1/2<1 mi
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCPhase 1<1 mi
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung CancerPhase 1<1 mi
Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsPhase 1<1 mi
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56Phase 1/2<1 mi
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®Phase 2<1 mi
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)Phase 2<1 mi
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility StudyN/A<1 mi
A Long-term Extension Study of PCI-32765 (Ibrutinib)Phase 3<1 mi
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerPhase 1/2<1 mi
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers—<1 mi
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)Phase 1/2<1 mi
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsPhase 1<1 mi
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung CancerPhase 1<1 mi
BBO-11818 in Adult Subjects With KRAS Mutant CancerPhase 1<1 mi
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 MutationsPhase 1/2<1 mi
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLCPhase 1/2<1 mi
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung CancerPhase 1/2<1 mi
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene AbnormalitiesPhase 1/2<1 mi
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsPhase 1/2<1 mi
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid TumorsPhase 1<1 mi
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASPhase 1/2<1 mi
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung CancerPhase 1<1 mi
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic DisordersPhase 2<1 mi
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia—<1 mi
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)Phase 1<1 mi
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasPhase 1/2<1 mi
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung CancerPhase 1<1 mi
First in Human Study of AZD9592 in Solid TumorsPhase 1<1 mi
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)Phase 1<1 mi
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing—<1 mi
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsPhase 1/2<1 mi
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)Phase 1/2<1 mi
Comprehensive Outcomes for After Cancer HealthN/A<1 mi
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic AlterationsPhase 1/2<1 mi
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerPhase 2<1 mi
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsPhase 1<1 mi
Ladarixin With Sotorasib in Advanced NSCLCPhase 1<1 mi
Safety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsPhase 1<1 mi
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)Phase 3<1 mi
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsPhase 1<1 mi
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C MutationPhase 2<1 mi
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsPhase 1<1 mi
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid TumorsPhase 1<1 mi
Confocal Laser Endomicroscopy VERificationN/A<1 mi
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine CancersPhase 2<1 mi
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other CancersPhase 1/2<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2<1 mi
Pembrolizumab for Advanced NSCLC and PS 2-3Phase 2<1 mi
A Study of LY4170156 in Participants With Selected Advanced Solid TumorsPhase 1<1 mi
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)Phase 2/3<1 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor TypesPhase 1/2<1 mi
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid TumorsPhase 1<1 mi
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid TumorsPhase 1/2<1 mi
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)Phase 1/2<1 mi
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)Phase 1/2<1 mi
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLCPhase 1/2<1 mi
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsPhase 2<1 mi
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsPhase 1/2<1 mi
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung CancerPhase 1/2<1 mi
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsPhase 1<1 mi
Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer—<1 mi
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCPhase 3<1 mi
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsPhase 1<1 mi
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)Phase 1<1 mi
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesPhase 1/2<1 mi
A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study—<1 mi
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C MutationPhase 1/2<1 mi
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsPhase 1<1 mi
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid TumorsPhase 1/2<1 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsPhase 3<1 mi
Lung Cancer Biomarkers and Screening—<1 mi
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.Phase 2/3<1 mi
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung CancerPhase 1/2<1 mi
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid TumorsPhase 1/2<1 mi
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung CancerPhase 3<1 mi
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Phase 3<1 mi
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)—<1 mi
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With PembrolizumabPhase 1/2<1 mi
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line TreatmentPhase 2<1 mi
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLCPhase 1/2<1 mi
A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsPhase 1<1 mi
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityPhase 3<1 mi
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerPhase 3<1 mi
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationPhase 1/2<1 mi
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver TransplantPhase 4<1 mi
FOG-001 in Locally Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/A<1 mi
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)—<1 mi
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate RetreatmentPhase 2/3<1 mi
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation—<1 mi
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid TumorPhase 1<1 mi
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialPhase 3<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)Phase 1<1 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsPhase 1/2<1 mi
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsPhase 2<1 mi
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCCPhase 1/2<1 mi
The Dragon PLC Trial (DRAGON-PLC)N/A<1 mi
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid MalignanciesPhase 1<1 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular CarcinomaPhase 1<1 mi
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaPhase 1<1 mi
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaPhase 1/2<1 mi
Brodalumab in the Treatment of Immune-Related Adverse EventsPhase 1<1 mi
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsPhase 1/2<1 mi
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary CancerPhase 2<1 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsPhase 1<1 mi
HOPE Against Cancer Recurrence in HCCPhase 4<1 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsPhase 1/2<1 mi
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before SurgeryPhase 2<1 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPhase 1/2<1 mi
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study of ZW251 in Participants With Advanced Solid TumorsPhase 1<1 mi
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)Phase 2<1 mi
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenPhase 3<1 mi
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver MetastasesPhase 2<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPhase 3<1 mi
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Phase 1/2<1 mi
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.Phase 24 mi
First-in-human Study of 7MW4911 in GI CancerPhase 1/24 mi
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPhase 14 mi
Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung CancerPhase 24 mi
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer—4 mi
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal CancerPhase 24 mi
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)Phase 24 mi
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedPhase 24 mi
ATATcH Alternating Treatment Plans for Advanced CancerPhase 24 mi
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentPhase 44 mi
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerPhase 24 mi
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 35 mi
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Phase 35 mi
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos StudyPhase 25 mi
Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)—5 mi
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)Phase 35 mi
Pilot Trial of Spiritual Care Interventions for Patients With CancerN/A5 mi
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders—5 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 35 mi
Mobile Health for Adherence in Breast Cancer PatientsN/A5 mi
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisPhase 35 mi
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck CancerPhase 25 mi
Leveraging the Emergency Department (LEAD) StudyN/A6 mi
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone LymphomaPhase 36 mi
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.Phase 28 mi
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)Phase 29 mi
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy DeliveryPhase 29 mi
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)Phase 29 mi
Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast CancerPhase 29 mi
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast CancerPhase 29 mi
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial CancerPhase 39 mi
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerPhase 29 mi
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerPhase 19 mi
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast CancersN/A9 mi
Liver Transplantation in Intrahepatic Cholangiocarcinoma—9 mi
A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell CarcinomaN/A9 mi
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7Phase 2/39 mi
RADIANT: Pre-op Radiation With Abemaciclib and LetrozolePhase 19 mi
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology—9 mi
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)Phase 39 mi
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer—10 mi
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics—11 mi
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)Phase 311 mi
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)Phase 311 mi
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health SystemN/A11 mi
Mosaic Trial for Stem Cell Transplant RecipientsN/A11 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerPhase 311 mi
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerPhase 312 mi
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)N/A12 mi
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic AlterationsPhase 312 mi
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors—12 mi
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer—12 mi
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialPhase 312 mi
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT—12 mi
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsPhase 112 mi
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung CancerPhase 212 mi
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 212 mi
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapyPhase 2/312 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)Phase 212 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)Phase 2/312 mi
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)Phase 312 mi
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)Phase 312 mi
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary BlastomaPhase 312 mi
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung CancerPhase 212 mi
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular CarcinomaPhase 212 mi
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabPhase 312 mi
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerPhase 312 mi
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerPhase 312 mi
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 112 mi
Upfront Surgical Resection for Osteosarcoma—12 mi
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and ActivityN/A12 mi
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate CancerPhase 412 mi
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsPhase 212 mi
Phase 1 Study of ACR-2316 in Specific Advanced Solid TumorsPhase 112 mi
Treatment of Radiation and Cisplatin Induced Toxicities with TempolPhase 212 mi
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial CancerPhase 312 mi
Molecular and Genomic Profiling of Head and Neck Tumors—12 mi
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysN/A12 mi
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2Phase 112 mi
A Study of JNJ-1761981 in Participants With Solid TumorsPhase 112 mi
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AMLPhase 112 mi
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.Phase 112 mi
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Phase 312 mi
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCCEarly 112 mi
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDSPhase 112 mi
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)N/A12 mi
First In Human Study of CX-2051 in Advanced Solid TumorsPhase 112 mi
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AMLPhase 212 mi
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian CancerPhase 312 mi
Phase I Study of Fractionated Stereotactic Radiation TherapyPhase 112 mi
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid TumorsPhase 112 mi
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid TumorsPhase 112 mi
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerPhase 212 mi
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaPhase 312 mi
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN LossPhase 212 mi
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal CancerPhase 112 mi
Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaPhase 1/212 mi
Reduced Intensity Haploidentical BMT for High Risk Solid TumorsPhase 212 mi
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder CancerPhase 112 mi
First in Human, Dose Escalation Study of AN4005Phase 112 mi
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate CancerPhase 212 mi
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy—12 mi
Digoxin Medulloblastoma StudyPhase 212 mi
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or OsteosarcomaPhase 1/212 mi
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid LeukemiaPhase 112 mi
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)Phase 112 mi
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponsePhase 312 mi
PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical DysplasiaPhase 212 mi
ZZ06 in Adult Patients With Advanced Solid Tumor MalignanciesPhase 112 mi
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With SarcomaPhase 1/212 mi
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesPhase 112 mi
Cardiovascular Multimodality Imaging Study—12 mi
Intra-Operative Radiation Registry—12 mi
Reiki Breast Surgery QOL Project for Women Undergoing Breast SurgeryN/A12 mi
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast CancerN/A12 mi
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXdPhase 212 mi
Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast CancerPhase 212 mi
Circulating Tumor DNAPhase 212 mi
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN TrialsN/A12 mi
EXoPERT EMERALD Clinical Study—12 mi
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung CancerPhase 212 mi
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLCPhase 212 mi
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)Phase 312 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialPhase 312 mi
Centralized Screening Unit (CSU) at Montefiore-EinsteinN/A12 mi
Cough Capture as a Portal Into the Lung—12 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 212 mi
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver CancerN/A12 mi
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCCPhase 212 mi
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme MalignanciesPhase 212 mi
Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With ImmunotherapyPhase 212 mi
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)Phase 212 mi
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate CancerPhase 1/212 mi
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)Phase 112 mi
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerPhase 2/312 mi
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)Phase 312 mi
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Phase 312 mi
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)—12 mi
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerPhase 212 mi
Shield Post-Approval Study Protocol—12 mi
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—12 mi
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsPhase 1/212 mi
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)Phase 1/212 mi
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE TrialPhase 312 mi
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid TumorsPhase 1/212 mi
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)Phase 212 mi
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)Phase 312 mi
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell CarcinomaPhase 2/312 mi
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)Phase 112 mi
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian CancersPhase 112 mi
Study of Erdafitinib Intravesical Delivery System for Localized Bladder CancerPhase 1/212 mi
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial TumorsPhase 212 mi
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsPhase 1/212 mi
DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine CancersPhase 112 mi
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsPhase 112 mi
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLPhase 212 mi
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes—12 mi
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)Phase 312 mi
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic MalignanciesPhase 112 mi
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid TumorsPhase 1/212 mi
XTX301 in Patients With Advanced Solid TumorsPhase 1/212 mi
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)Phase 212 mi
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or PancreasPhase 112 mi
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)Phase 212 mi
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)Phase 1/212 mi
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromePhase 212 mi
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical ProstatectomyPhase 212 mi
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland TreatmentN/A12 mi
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple MyelomaPhase 1/212 mi
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's LymphomaPhase 112 mi
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1/212 mi
Pediatric Precision Laboratory Advanced Neuroblastoma TherapyPhase 212 mi
Embryonal Tumor With Multilayered RosettesPhase 212 mi
Pembrolizumab and Lenvatinib in Advanced Cervical CancerPhase 212 mi
A Study of BG-C477 in Participants With Advanced Solid TumorsPhase 112 mi
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyPhase 312 mi
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)Phase 312 mi
A Global Study of the PETAL Consortium—12 mi
Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid TumorsPhase 112 mi
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome—12 mi
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1Phase 112 mi
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory NeuroblastomaPhase 212 mi
Phase IB/II of CPX-351 for Relapse Prevention in AMLPhase 1/212 mi
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple MyelomaPhase 112 mi
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed MedulloblastomaPhase 212 mi
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Phase 312 mi
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerPhase 312 mi
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast CancerPhase 1/212 mi
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid TumorsPhase 1/212 mi
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsPhase 1/212 mi
Post-operative Urinary Retention (POUR) Following Thoracic SurgeryPhase 1/212 mi
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)Phase 1/212 mi
CT-95 in Advanced Cancers Associated With Mesothelin ExpressionPhase 112 mi
Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung CancerPhase 212 mi
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaPhase 112 mi
A Phase 1 Study of LNCB74 in Advanced Solid TumorsPhase 112 mi
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic SarcomaPhase 212 mi
A Study of ZL-1310 in Subjects With Small Cell Lung CancerPhase 112 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.Phase 112 mi
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsPhase 112 mi
Support for Cancer Patients Awaiting NewsN/A12 mi
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid TumorsPhase 1/212 mi
A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsPhase 112 mi
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)Phase 1/212 mi
RAPA-201 Therapy of Solid TumorsPhase 1/212 mi
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)Phase 112 mi
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsPhase 1/212 mi
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursPhase 1/212 mi
Evaluating Novel Therapies in ctDNA Positive GI CancersPhase 312 mi
Testing RG1-VLP Vaccine to Prevent HPV-related CancersPhase 113 mi
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer SurvivorsN/A13 mi
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE TrialPhase 313 mi
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-—13 mi
Ultralow Dose PET Imaging for PSMA ExpressionPhase 213 mi
Ultralow Dose PET Imaging of 18F-FDG UptakePhase 213 mi
Ultralow Dose PET Imaging of SSTR2 Radiotracer UptakePhase 213 mi
Ultralow Dose PET Imaging for 18F-NaF UptakePhase 213 mi
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)—13 mi
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial HepatectomyN/A13 mi
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha ExpressionPhase 213 mi
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other TherapiesPhase 213 mi
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) TrialN/A13 mi
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecPhase 214 mi
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaPhase 216 mi
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCCPhase 116 mi
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid TumorsPhase 1/216 mi
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry—16 mi
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Phase 316 mi
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal CancerPhase 2/316 mi
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver MetastasisEarly 116 mi
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsPhase 316 mi
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected SarcomasPhase 1/216 mi
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their BodyPhase 1/216 mi
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)Phase 316 mi
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia GravisN/A16 mi
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S TrialPhase 316 mi
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk CohortN/A16 mi
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid TumorsPhase 116 mi
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)Phase 116 mi
A Study of GEN1106 in Participants With Solid TumorsPhase 116 mi
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPhase 1/216 mi
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of DiseasePhase 216 mi
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)Phase 116 mi
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid TumorsPhase 116 mi
DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade GliomaPhase 1/216 mi
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsPhase 1/216 mi
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyPhase 216 mi
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast CancerPhase 116 mi
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsPhase 1/216 mi
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)Phase 216 mi
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastasesEarly 116 mi
A Phase 1 Study of the Safety and Tolerability of CTX-10726Phase 116 mi
A Study of MGC026 in Participants With Advanced Solid TumorsPhase 116 mi
Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)—16 mi
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung CancerPhase 2/316 mi
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)Phase 316 mi
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)Phase 216 mi
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on OsimertinibPhase 1/216 mi
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)—17 mi
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic CancerEarly 117 mi
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic CancerPhase 1/217 mi
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal AdenocarcinomaN/A17 mi
Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)Phase 117 mi
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal MelanomaPhase 217 mi
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal SamplesN/A17 mi
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase InhibitorsN/A17 mi
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Phase 317 mi
Virtual Personalized Exercise Program for Lung Cancer PatientsN/A17 mi
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management—17 mi
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs—17 mi
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerPhase 217 mi
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)Phase 1/217 mi
National Liver Cancer Screening TrialPhase 417 mi
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone MetasPhase 217 mi
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaPhase 317 mi
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaPhase 317 mi
Investigating Targetable Metabolic Pathways Sustaining Pancreatic CancerN/A17 mi
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TPhase 218 mi
An Internet-based Program to Help Cancer Survivors Manage PainN/A19 mi
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and FatiguePhase 2/319 mi
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerPhase 319 mi
Collection of Sputum and Labeling for Lung Cancer—19 mi
Measuring Surgical Recovery After Radical Cystectomy—19 mi
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)Phase 220 mi
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria—20 mi
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainPhase 220 mi
Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic CancerPhase 221 mi
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCPhase 321 mi
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic LeukemiaPhase 221 mi
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell MalignanciesPhase 221 mi
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal CancerPhase 221 mi
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast TumorsN/A21 mi
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies—21 mi
A Study of DB-1310 in Advanced/Metastatic Solid TumorsPhase 1/221 mi
A Study of Enasidenib in People With T-Cell LymphomaPhase 222 mi
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaPhase 322 mi
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerPhase 222 mi
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin LymphomaPhase 122 mi
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone LymphomaPhase 322 mi
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell MalignanciesPhase 122 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)Phase 322 mi
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung CancerPhase 322 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLCPhase 322 mi
The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey—25 mi
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid TumorsPhase 1/225 mi
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin LymphomaPhase 1/225 mi
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesPhase 125 mi
Rutgers University Study of the Genetics of Breast Cancer.—25 mi
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)Phase 226 mi
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)Phase 2/326 mi
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerPhase 126 mi
Study of NALIRIFOX in Advanced Unresectable Small Bowel TumorsPhase 226 mi
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid TumorsPhase 126 mi
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid TumorsPhase 1/226 mi
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenN/A26 mi
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)Phase 226 mi
Pancreatic Cancer Detection Consortium—26 mi
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AMLPhase 2/326 mi
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)Phase 326 mi
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)Phase 326 mi
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerPhase 1/226 mi
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 ChangePhase 226 mi
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung CancerPhase 326 mi
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)Phase 226 mi
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)Phase 326 mi
Observational Study Protocol: LIVER-R—26 mi
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerPhase 327 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.Phase 327 mi
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase 327 mi
The Leukemia and Lymphoma Society (LLS) National Research Registry—27 mi
Clinical Utility of WATS3D: A 5-Year Prospective Study—28 mi
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CarePhase 328 mi
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural MesotheliomaPhase 328 mi
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell DepletionPhase 228 mi
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive ChemotherapyPhase 228 mi
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)Phase 1/228 mi
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV InfectionPhase 228 mi
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaEarly 128 mi
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCLPhase 228 mi
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS MalignanciesPhase 128 mi
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin LymphomaPhase 1/228 mi
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid TumorsPhase 128 mi
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLPhase 228 mi
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerPhase 328 mi
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell LymphomaPhase 328 mi
A Youth-led Intervention to Reduce Healthcare Disparities in Cancer ScreeningN/A28 mi
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer SurvivorsN/A28 mi
Effects of Latin Dancing on Sleep Quality in Hispanic Cancer SurvivorsN/A28 mi
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid TumorsPhase 128 mi
Spine Oncology Registry—28 mi
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid MalignanciesPhase 1/228 mi
Addressing Genomic Disparities in Cancer SurvivorsN/A28 mi
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck CancerPhase 1/228 mi
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)Phase 328 mi
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin LymphomaPhase 1/228 mi
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)Phase 128 mi
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)Phase 228 mi
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone LymphomaPhase 228 mi
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLPhase 328 mi
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin LymphomaPhase 128 mi
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell CarcinomaPhase 328 mi
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal CancerPhase 228 mi
MySmartSkin Online Skin Self-exam Intervention for Melanoma SurvivorsN/A28 mi
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell MobilizationEarly 128 mi
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)Phase 128 mi
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial CarcinomaPhase 228 mi
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.Phase 228 mi
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid TumorsPhase 128 mi
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy—28 mi
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)Phase 228 mi
MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial—28 mi
Bright Ideas - CIN Feasibility StudyN/A28 mi
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)Phase 1/228 mi
A Mobile Health Intervention Among HispanicsN/A28 mi
Naltrexone and Propranolol Combined With ImmunotherapyPhase 128 mi
Reducing Urban Cervical Cancer DisparitiesN/A28 mi
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular LymphomaPhase 228 mi
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated CancersPhase 228 mi
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate CancerPhase 1/228 mi
SynKIR-310 for Relapsed/Refractory B-NHLPhase 128 mi
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersPhase 1/228 mi
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid TumorsPhase 128 mi
Project CARE: CAncer Risk EvaluationN/A28 mi
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)Phase 1/228 mi
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast CancerN/A28 mi
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerPhase 1/228 mi
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerN/A28 mi
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for HispanicsN/A28 mi
TELESCOPE- TELEhealth Shared Decision-making COachingN/A28 mi
KO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsPhase 128 mi
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung CancerN/A28 mi
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung CancerPhase 128 mi
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cmPhase 228 mi
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy—28 mi
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)Phase 229 mi
A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaPhase 129 mi
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast CancerPhase 229 mi
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerPhase 2/329 mi
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsPhase 1/229 mi
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsPhase 129 mi
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsPhase 1/229 mi
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsPhase 329 mi
The CDK4/6 Inhibitor Dosing Knowledge (CDK) StudyPhase 329 mi
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid CancerPhase 329 mi
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene MutationPhase 229 mi
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersPhase 229 mi
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast CancerPhase 1/229 mi
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung CancerPhase 1/229 mi
Rectal Spacers Use in Prostate Cancer Radiation TherapyN/A29 mi
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP DeletionPhase 2/329 mi
PROton Therapy for Post Surgical Treatment of GYNecologic CancerPhase 230 mi
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerPhase 330 mi
The Radiation Oncology Registry and Biosample Repository—30 mi
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III TrialPhase 330 mi
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During ChemotherapyN/A30 mi
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyN/A30 mi
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast CancerPhase 230 mi
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic AlterationsPhase 330 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)Phase 230 mi
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier—34 mi
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS MutationsPhase 334 mi
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCLPhase 234 mi
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBCPhase 234 mi
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)Phase 334 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening—34 mi
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerPhase 1/234 mi
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerPhase 135 mi
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With RavulizumabPhase 435 mi
Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced CancerN/A37 mi
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial CancerPhase 2/337 mi
Molecular Genetics Studies of Cancer Patients and Their Relatives—37 mi
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerPhase 1/238 mi
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2Phase 238 mi
Caris Biorepository Research Protocol—40 mi
A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical TrialsN/A41 mi
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer—42 mi
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C MutationPhase 342 mi
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals—42 mi
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus—42 mi
Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)—43 mi
A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast CancerPhase 143 mi
Phase 1 Study of CLR 125 in Triple Negative Breast CancerPhase 143 mi
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid TumorsPhase 1/243 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)Phase 1/243 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 243 mi
Decision Aid and Thyroid Nodules ManagementN/A48 mi
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCTPhase 348 mi
Raman Spectroscopy and Skin Cancer—48 mi
Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer SurvivorsN/A48 mi
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple MyelomaPhase 248 mi
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)Phase 348 mi
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple MyelomaPhase 348 mi
Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma MultiformeEarly 148 mi
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)—48 mi
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast CancerPhase 148 mi
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast CancerEarly 148 mi
Definitive Radiation Therapy for Inoperable Breast CancerN/A48 mi
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesPhase 248 mi
CtDNA Based MRD Testing for NAC Monitoring in TNBC—48 mi
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 2/348 mi
Definitive Radiation for High-Risk Spine MetastasesPhase 248 mi
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer SurvivorsN/A48 mi
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM StudyPhase 249 mi
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]Phase 349 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.